GDAP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.524200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.243400E-01
Normal-vs-Stage2
9.192600E-01
Normal-vs-Stage3
3.265600E-01
Normal-vs-Stage4
7.009800E-01
Stage1-vs-Stage2
2.001000E-01
Stage1-vs-Stage3
1.401620E-01
Stage1-vs-Stage4
4.713200E-01
Stage2-vs-Stage3
5.323000E-01
Stage2-vs-Stage4
4.207800E-01
Stage3-vs-Stage4
3.771000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.748560E-01
Normal-vs-AfricanAmerican
9.499600E-01
Normal-vs-Asian
2.414800E-01
Caucasian-vs-AfricanAmerican
3.053600E-01
Caucasian-vs-Asian
1.843410E-03
AfricanAmerican-vs-Asian
2.787600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.587400E-01
Normal-vs-Female
7.983400E-01
Male-vs-Female
8.197800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.611600E-01
Normal-vs-Age(41-60Yrs)
7.437200E-01
Normal-vs-Age(61-80Yrs)
2.625000E-01
Normal-vs-Age(81-100Yrs)
8.386600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.221400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.538400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.584500E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.481400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.984630E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.676430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.884800E-01
Normal-vs-Daily Drinker
8.799200E-01
Normal-vs-Weekly Drinker
7.325400E-01
Normal-vs-Occasional Drinker
2.220800E-01
Normal-vs-Social Drinker
3.677000E-01
Non Drinker-vs-Daily Drinker
2.020800E-01
Non Drinker-vs-Weekly Drinker
7.706000E-01
Non Drinker-vs-Occasional Drinker
1.247440E-01
Non Drinker-vs-Social Drinker
1.680430E-01
Daily Drinker-vs-Weekly Drinker
4.472400E-01
Daily Drinker-vs-Occasional Drinker
2.870400E-01
Daily Drinker-vs-Social Drinker
5.012600E-01
Weekly Drinker-vs-Occasional Drinker
1.586610E-01
Weekly Drinker-vs-Social Drinker
2.385200E-01
Occasional Drinker-vs-Social Drinker
6.111400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.587400E-01
Normal-vs-Grade 2
1.493180E-01
Normal-vs-Grade 3
1.110370E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.165800E-02
Grade 1-vs-Grade 3
3.556300E-02
Grade 1-vs-Grade 4
3.587400E-01
Grade 2-vs-Grade 3
8.635400E-01
Grade 2-vs-Grade 4
1.493180E-01
Grade 3-vs-Grade 4
1.110370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.065200E-01
Normal-vs-NonDiabetic
1.972800E-01
Diabetic-vs-NonDiabetic
1.008810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.850400E-02
Normal-vs-NoPancreatitis
2.246800E-01
Pancreatitis-vs-NoPancreatitis
4.394500E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.865600E-02
Normal-vs-N1
9.943400E-01
N0-vs-N1
6.495600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.646600E-01
Normal-vs-TP53-NonMutant
1.368250E-02
TP53-Mutant-vs-TP53-NonMutant
2.484600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
